CN104135954A - 膜及制造方法 - Google Patents

膜及制造方法 Download PDF

Info

Publication number
CN104135954A
CN104135954A CN201280070872.4A CN201280070872A CN104135954A CN 104135954 A CN104135954 A CN 104135954A CN 201280070872 A CN201280070872 A CN 201280070872A CN 104135954 A CN104135954 A CN 104135954A
Authority
CN
China
Prior art keywords
polymer solution
film
polymer
mould
methods according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201280070872.4A
Other languages
English (en)
Other versions
CN104135954B (zh
Inventor
D.阿姆布鲁斯特
J.德耶
J.乔姆恩
S.科尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthes GmbH
DePuy Synthes Products Inc
Original Assignee
Synthes GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthes GmbH filed Critical Synthes GmbH
Publication of CN104135954A publication Critical patent/CN104135954A/zh
Application granted granted Critical
Publication of CN104135954B publication Critical patent/CN104135954B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/80—Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/70—Spinal positioners or stabilisers ; Bone stabilisers comprising fluid filler in an implant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/70—Spinal positioners or stabilisers ; Bone stabilisers comprising fluid filler in an implant
    • A61B17/7097—Stabilisers comprising fluid filler in an implant, e.g. balloon; devices for inserting or filling such implants
    • A61B17/7098—Stabilisers comprising fluid filler in an implant, e.g. balloon; devices for inserting or filling such implants wherein the implant is permeable or has openings, e.g. fenestrated screw
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/80—Cortical plates, i.e. bone plates; Instruments for holding or positioning cortical plates, or for compressing bones attached to cortical plates
    • A61B17/8028—Cushions, i.e. elements forming interface between bone plate and bone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/003—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor characterised by the choice of material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/02—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C39/026—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles characterised by the shape of the surface
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/22—Component parts, details or accessories; Auxiliary operations
    • B29C39/24—Feeding the material into the mould
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/22—Component parts, details or accessories; Auxiliary operations
    • B29C39/26—Moulds or cores
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/22—Component parts, details or accessories; Auxiliary operations
    • B29C39/38—Heating or cooling
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D7/00—Producing flat articles, e.g. films or sheets
    • B29D7/01—Films or sheets
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18—Manufacture of films or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526—Methods of manufacturing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B2017/561—Implants with special means for releasing a drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063—Implantable repair or support meshes, e.g. hernia meshes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A61F2/2846—Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30907—Nets or sleeves applied to surface of prostheses or in cement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006—Properties of materials and coating materials
    • A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006—Properties of materials and coating materials
    • A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • A61F2002/30064—Coating or prosthesis-covering structure made of biodegradable material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006—Properties of materials and coating materials
    • A61F2002/30065—Properties of materials and coating materials thermoplastic, i.e. softening or fusing when heated, and hardening and becoming rigid again when cooled
    • A61F2002/30067—Coating or prosthesis-covering structure made of thermoplastic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006—Properties of materials and coating materials
    • A61F2002/30069—Properties of materials and coating materials elastomeric
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30907—Nets or sleeves applied to surface of prostheses or in cement
    • A61F2002/30919—Sleeves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00217—Wound bandages not adhering to the wound
    • A61F2013/00221—Wound bandages not adhering to the wound biodegradable, non-irritating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00089—Wound bandages
    • A61F2013/00357—Wound bandages implanted wound fillings or covers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
    • A61F2250/0031—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2067/00—Use of polyesters or derivatives thereof, as moulding material
    • B29K2067/04—Polyesters derived from hydroxycarboxylic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2067/00—Use of polyesters or derivatives thereof, as moulding material
    • B29K2067/04—Polyesters derived from hydroxycarboxylic acids
    • B29K2067/043—PGA, i.e. polyglycolic acid or polyglycolide
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2067/00—Use of polyesters or derivatives thereof, as moulding material
    • B29K2067/04—Polyesters derived from hydroxycarboxylic acids
    • B29K2067/046—PLA, i.e. polylactic acid or polylactide
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0002—Condition, form or state of moulded material or of the material to be shaped monomers or prepolymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
    • B29K2105/0035—Medical or pharmaceutical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0058—Liquid or visquous
    • B29K2105/0073—Solution
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
    • B29K2995/0037—Other properties
    • B29K2995/0059—Degradable
    • B29K2995/006—Bio-degradable, e.g. bioabsorbable, bioresorbable or bioerodible
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2007/00—Flat articles, e.g. films or sheets
    • B29L2007/008—Wide strips, e.g. films, webs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
    • C08J2367/04—Polyesters derived from hydroxy carboxylic acids, e.g. lactones
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2369/00—Characterised by the use of polycarbonates; Derivatives of polycarbonates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L69/00—Compositions of polycarbonates; Compositions of derivatives of polycarbonates
    • C08L69/005—Polyester-carbonates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S525/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S525/937—Utility as body contact e.g. implant, contact lens or I.U.D.
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24174—Structurally defined web or sheet [e.g., overall dimension, etc.] including sheet or component perpendicular to plane of web or sheet
    • Y10T428/24182—Inward from edge of web or sheet
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24273—Structurally defined web or sheet [e.g., overall dimension, etc.] including aperture
    • Y10T428/24281—Struck out portion type
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24479—Structurally defined web or sheet [e.g., overall dimension, etc.] including variation in thickness
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/25—Web or sheet containing structurally defined element or component and including a second component containing structurally defined particles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/26—Web or sheet containing structurally defined element or component, the element or component having a specified physical dimension

Abstract

本发明公开了一种柔性体，所述柔性体包括具有第一表面和相对的第二表面的聚合物膜。所述聚合物膜具有从所述第一表面延伸到所述第二表面的多个孔以及从所述第一表面突起的多个升高唇缘，使得所述多个孔中的每一个被所述多个升高唇缘中的一个围绕。本发明公开了一种制备聚合物膜的方法，所述方法包括将聚合物溶液置于具有从模具的底部延伸的多个突起的单面模具中，其中所述聚合物溶液的特征在于抑制所述聚合物无外力流遍所述模具的粘度；促动所述聚合物溶液围绕所述多个突起中的每一个；以及固化所述聚合物溶液。

Description

膜及制造方法
相关申请的交叉引用
本申请要求于2011年12月28日提交的名称为“Films and Methods ofManufacture”的美国临时专利申请No.61/580,679的权益，该临时专利申请据此以引用的方式全文并入。
背景技术
本发明整体涉及膜(例如聚合物膜)及制造方法，并在至少一些实施例中涉及用于医疗用途的穿孔膜及制造方法。
发明内容
在一个实施例中，存在一种柔性体，该柔性体包含具有第一表面和相对的第二表面的膜(例如聚合物膜)，该膜具有从第一表面延伸到第二表面的多个孔以及从第一表面突起的多个升高唇缘，使得多个孔中的每一个被多个升高唇缘中的一个围绕。在一个优选实施例中，膜由聚合材料(即聚合物膜)构成。在一个实施例中，聚合物膜包含生物吸收性聚合物。在一个实施例中，生物吸收性聚合物包含选自以下的重复单元：L-乳酸、D-乳酸、L-丙交酯、D-丙交酯、D,L-丙交酯、乙交酯、内酯、内酰胺、三亚甲基碳酸酯、环状碳酸酯、环醚、对二氧环己酮、β-羟基丁酸、β-羟基丙酸、β-羟基戊酸，以及它们的组合。在一个实施例中，生物吸收性聚合物包含选自以下的重复单元：L-乳酸、D-乳酸、L-丙交酯、D-丙交酯、D,L-丙交酯、ε-己内酯、三亚甲基碳酸酯、对二氧环己酮，以及它们的组合。在一个实施例中，生物吸收性聚合物是乙交酯、三亚甲基碳酸酯、丙交酯和己内酯的共聚物。
在一个实施例中，第一表面包括在所述多个升高的突起唇缘之间延伸的邻接平面部分。在一个实施例中，所述多个升高的突起唇缘各自具有比邻接平面部分高约0.1mm至约1.0mm的外边缘。在一个实施例中，聚合物膜包含多种离散的洗脱药物组分，并且其中聚合物膜被配置成在植入柔性体后在不同时间段洗脱所述多种离散的药物组分。在另一个实施例中，柔性体包含被配置成将聚合物膜形成鞘管的至少一个接缝。在一个实施例中，聚合物膜在第一平面方向上具有第一拉伸强度并在垂直于第一平面方向的第二平面方向上具有第二拉伸强度，其中第一拉伸强度基本上等于第二拉伸强度。在一个实施例中，聚合物膜具有不大于0.06mm的标称厚度。在一个实施例中，第一表面具有不同于第二表面的第二触感的第一触感。
在另一个实施例中，存在一种制备聚合物膜的方法，包括：将聚合物溶液置于具有从模具底部延伸的多个突起的单面模具中，其中该聚合物溶液的特征在于抑制聚合物无外力流遍模具的粘度；促动聚合物溶液围绕所述多个突起中的每一个；以及固化聚合物溶液。在一个实施例中，模具包括延伸高度基本上等于所述多个突起中的每一个的高度的围型体(perimeterform)。在一个实施例中，促动包括拉引促动装置(诸如刀片、条、橡皮扫帚或辊)横跨围型体和所述多个突起，以迫使聚合物溶液围绕所述多个突起流动并流遍模具，使得聚合物溶液具有基本上均匀的厚度。在一个实施例中，突起中的每一个的外表面在拉引后基本上不含聚合物溶液。在一个实施例中，放置步骤包括将聚合物溶液沉积在模具中，使得聚合物溶液的一部分在围型体和突起的高度以上。
在一个实施例中，固化聚合物溶液包括减小聚合物溶液的厚度。在一个实施例中，固化聚合物溶液包括围绕所述多个突起中的每一个形成固化聚合物的弯月面。在一个实施例中，从模具的底部到所述多个突起中的每一个的顶部的距离小于约0.3mm。在一个实施例中，聚合物溶液包含药物。在一个实施例中，聚合物溶液通过在低于90℃的温度下混合溶剂、聚合物和药物而形成。在一个实施例中，围型体限定总模具面积，并且所述多个突起限定总模具面积的至少约15％的面积。在另一个实施例中，该方法包括将药物洗脱膜从模具剥离。
在一个实施例中，聚合物溶液包括可交联的预聚物溶液。在一个实施例中，固化步骤包括通过向聚合物溶液施加UV辐射、温度改变、聚合催化剂、可溶性交联剂或它们的组合而交联聚合物。在一个实施例中，聚合物溶液包括离散的药物单元。在一个实施例中，聚合物溶液包含第一溶剂和聚合物，并且固化步骤包括将聚合物溶液暴露于第二溶剂，在第二溶剂中，第一溶剂是可溶的并且聚合物和药物是不可溶的，使得将第一溶剂至少基本上从聚合物溶液中移除，并且该聚合物固化以包含药物。
附图说明
上文的概述以及下文的聚合物膜及制造方法的实施例的具体实施方式在结合示例性实施例的附图阅读时将更好地理解。然而应当理解，本发明不限于所示的精确布置方式和工具。
在附图中：
图1A是根据本发明的示例性实施例的膜(在此情况下为聚合物膜)的一部分的放大透视示意图；
图1B是根据本发明的示例性实施例的聚合物膜的孔的60倍放大照片；
图2是由图1B的聚合物膜形成的三个示例性鞘管与相应植入式医疗装置结合的顶视图；
图3A是根据本发明的示例性实施例的模具的一部分的透视照片；
图3B是图3A的模具的顶部平面图；
图3C是沿着图3B中的线C-C截取的图3B的模具的横截面侧视图；
图3D是在图3B中所示的模具的放大角落截面图；
图3E是沿着线B-B截取的图3D中所示的模具的放大截面图；
图3F是图3A的模具的放大透视照片；
图3G是根据本发明的另一示例性实施例的模具的放大透视照片；
图4A是添加了聚合物的图3A的模具的示意性侧向截面图；
图4B是图4A中所示的模具的示意性侧向截面图，示出了将聚合物拉引横跨模具的拉引装置；
图4C是图4A中所示的模具的示意性侧向截面图，示出了在被拉引横跨模具并固化以形成聚合物膜后的聚合物；
图5是根据本发明的示例性实施例的自动化浇铸设备的透视图；
图6是图5的自动化浇铸设备的透视图，示出了添加到模具的聚合物；
图7是图5的自动化浇铸设备的透视图，示出了拉引聚合物横跨模具的拉引装置；
图8是添加到根据本发明的另一示例性实施例的模具的聚合物的透视图；
图9是图8的模具的透视图，示出了拉引聚合物横跨模具的拉引装置；
图10是图8的模具的透视图，示出了从模具移除的聚合物膜；
图11A是使用以第一构型所示的图1的聚合物膜形成的鞘管的顶部平面图；
图11B是使用以第二构型所示的图1的聚合物膜形成的鞘管的顶部平面图；
图11C是使用以第三构型所示的图1的聚合物膜形成的鞘管的顶部平面图；
图11D是使用以第四构型所示的图1的聚合物膜形成的鞘管的顶部平面图；
图11E是在图11D中的圆圈B内的区域；
图11F是诸如图11A-11D所示的那些的鞘管的接缝的放大视图；
图12是根据本发明的示例性实施例的聚合物膜的屈服应力图；
图13是根据本发明的示例性实施例的聚合物膜的屈服应变图；
图14是曲线图，示出了当将根据本发明的示例性实施例的套管置于盐水溶液中时药物随着时间的释放速率；
图15是根据本发明的示例性实施例的聚合物膜的体外质量损失图；并且
图16是根据本发明的示例性实施例的聚合物膜的体外分子量损失图。
具体实施方式
在整形外科或创伤手术中，感染是一大挑战。虽然有诸如无菌操作和消毒的预防措施，但是手术部位仍是局部病原体的进入部位使得变成有毒力的并引起感染。
用诸如抗生素的药物涂布植入式装置对于减少感染已是有效的。然而，鉴于植入体和其他医疗装置的大数量、尺寸和形状，对每一装置提供涂层的监管、经济和物流负担是庞大的。若考虑在涂层中使用另外的药物诸如止痛药、抗肿瘤剂和生长促进物质，则该问题会更严重。
本发明的实施例涉及改进的穿孔聚合物膜及其新型浇铸制造方法。在一些实施例中，膜与植入式医疗装置一同使用，但是膜可用于任何应用。
现存的形成穿孔膜的商业方法通常涉及形成固体膜的第一步骤，然后在膜中钻孔或切孔的第二步骤。本文所述的实施例的至少一些中的优点在于：在形成膜的同时，形成膜的孔或穿孔。这在以下情况中可以是有用的：当形成的聚合物膜极薄并且因随后的处理或加工而存在损坏的风险时，或当膜的厚度和/或强度使其难以通过传统方法钻孔或切割而不损坏该膜时。这种方法在以下情况中也可以是有利的：当聚合物溶液包含可受随后的切割或穿孔步骤损坏的药物或其他活性剂时。
本发明的实施例也可用于制备大量的浇铸膜，诸如那些被认为太小而不能通过传统方法(通常为设计用于大量制备的连续方法)经济地制备的膜。本发明的至少一些实施例的额外优点在于：在浇铸片材中形成的穿孔可具有复杂的形状。本发明的至少一些实施例的另一优点在于：膜的至少一侧可被形成为具有不平的表面，其在一些实施例中增加摩擦并给予改善的触感。本发明的这些优点以及其他优点在下文更详细地说明。
详细参考附图，其中相同的附图标记在全文中表示相同的元件，在图1A和1B中示出了根据本发明的示例性实施例的通常标为10的聚合物膜和通常标为18的模具。
参考图1A的实施例，膜10(例如聚合物膜)是具有第一表面10a和相对的第二表面10b的柔性体。
在一个实施例中，膜10可由单个生物相容性材料薄片形成。在一个实施例中，膜10由两个或更多个片材材料构成。在一个优选实施例中，生物相容性材料是生物吸收性的。在与医疗装置12(参见图2)一起使用的实施例中，膜10在一些实施例中当植入体内时将随着时间溶解并被患者吸收，使得仅留下医疗装置12(诸如，如果医疗装置12并非也由生物吸收性材料制成)。医疗装置12在其他实施例中也可由生物吸收性材料制成，在此情况下，医疗装置12和膜10最后将溶解。在一些实施例中，膜10可被配置成以与吸收性医疗装置12不同的速率(例如更快或更慢的速率)吸收。
在一些实施例中，生物吸收性膜10比非吸收性筛网更具优势，筛网例如可变得被致密的纤维组织包裹或嵌入其中，或存在与长期外来物暴露相关的其他问题。在一些实施例中，膜10是仅部分可生物吸收的。
可使用生物吸收性聚合物以便提供具有有限终点的药物(诸如抗生素)的控制释放。抗生素的连续、长期存在通常是不可取的，因为这会形成产生抗生素耐药细菌的条件。在一个实施例中，膜10的完全降解确保药物将在预定的和/或可选的时间完全释放。在一个实施例中，即使在膜10未被完全吸收的情况下，药物释放也可完全释放或基本上完全释放。
膜10的吸收也可影响和/或控制抗生素在连续释放期中的释放。随着膜降解，例如膜的渗透性可增加，并且可释放出更多的药物。在一些实施例中，所用的聚合物对于柔性的结构而言必须具有相对高的拉伸强度，并能通过溶液浇铸而加工。在一个实施例中，膜10由包含以下四种单体中的一种或多种的共聚物构成：乙交酯、丙交酯、己内酯和三亚甲基碳酸酯。乙交酯可包含在内并可具有使膜10的降解加速的效果。丙交酯也可包含在内并可具有增强膜10的机械强度的效果。己内酯和三亚甲基碳酸酯可使用并可具有增加膜10的柔性的效果。
在一个实施例中，生物吸收性聚合物包括PLA、PGA、聚己内酯、聚二氧杂环己酮、TMC以及它们的共聚物中的一者或多者。在一个实施例中，生物吸收性聚合物由乙醇酸、己内酯、乳酸和三亚甲基碳酸酯的共聚物制成。在一个实施例中，生物吸收性聚合物由约60％的乙醇酸、约20％的己内酯、约10％的乳酸以及约10％的三亚甲基碳酸酯的共聚物制成。在一个实施例中，生物吸收性聚合物包含选自以下的重复单元：L-乳酸、D-乳酸、L-丙交酯、D-丙交酯、D,L-丙交酯、乙交酯、内酯、内酰胺、三亚甲基碳酸酯、环状碳酸酯、环醚、对二氧环己酮、β-羟基丁酸、β-羟基丙酸、β-羟基戊酸，以及它们的组合。在一个实施例中，生物吸收性聚合物包含选自以下的重复单元：L-乳酸、D-乳酸、L-丙交酯、D-丙交酯、D,L-丙交酯、ε-己内酯、三亚甲基碳酸酯、对二氧环己酮，以及它们的组合。在一个实施例中，生物吸收性聚合物是乙交酯、三亚甲基碳酸酯、丙交酯和己内酯的共聚物。另外或替代地，膜10也可包含天然的生物聚合物，诸如藻酸盐、脱乙酰壳多糖、胶原、明胶、透明质酸盐、玉米蛋白等。
仍参考图1A，膜10可被配置成具有任何优选的尺寸，包括在第一表面10a与第二表面10b之间而排除在图1A和1B中所示的围绕孔14的升高唇缘14a所测得的厚度h3。在一个实施例中，膜10必须足够薄，使得其不干扰在板12与用于固定的螺钉之间的机械互锁(诸如在将膜限制在板与螺钉之间的情况下)。在一些实施例中，厚度h3尽可能最小化。在一个实施例中，选择膜10的厚度，使得膜10的降解不会造成与医疗装置12的连接(诸如板-螺钉构造)的明显松弛。
在一些实施例中，膜10的厚度h3为约0.05mm。在一些实施例中，膜10的厚度h3为约不大于0.05mm。在一些实施例中，膜10的厚度h3小于约0.05mm。在一些实施例中，膜10的厚度h3为约0.06mm。在一些实施例中，膜10的厚度h3为约0.07mm。在一些实施例中，膜10的厚度h3为约0.08mm。在一些实施例中，膜10的厚度h3为约0.09mm。在一些实施例中，膜10的厚度h3为约0.1mm。在一些实施例中，膜10的厚度h3为约0.2mm。在一些实施例中，膜10的厚度h3为约0.3mm。在一些实施例中，膜10的厚度h3为约0.4mm。在一些实施例中，膜10的厚度h3为约0.5mm。
在一个实施例中，膜10的厚度h3在整个膜10中大致均匀。在一些实施例中，膜10朝着沿外周边的一个或多个边缘渐缩。在一些实施例中，膜10的厚度h3在两个或更多个部分中不同，以控制各区域的强度或药物递送。
在一些实施例中，膜10必须具有足够的强度以经受机械力，诸如植入、钻孔和螺钉放置。在一个实施例中，膜10在第一平面方向上具有第一拉伸强度并在垂直于第一平面方向的第二平面方向上具有第二拉伸强度，其中第一拉伸强度基本上等于第二拉伸强度。在一个实施例中，膜10具有如下表1-3所列的强度特性。
表1
表2
表3
膜样品 断裂拉伸应力(标准)(MPa) 模量(自动杨氏)(MPa)
1 15.20147 749.15765
2 21.71590 504.50877
3 19.08817 657.83084
4 18.08469 574.31825
5 18.71550 618.69300
6 21.75346 436.82724
平均值 19.09320 590.22262
标准偏差 2.460 111.150
变异系数 12.885 18.832
在一个实施例中，膜10具有约2％至约4％的屈服拉伸应变(偏置量0.2％)和/或约3％的平均拉伸应变。在一个实施例中，膜10具有约9MPa至约14MPa的屈服拉伸应力(偏置量0.2％)和/或约12.5MPa的平均屈服拉伸应力。在一个实施例中，膜10具有约25MPa至约30MPa的最大负荷下的拉伸应力和/或约27MPa的最大负荷下的平均拉伸应力。在一个实施例中，膜10具有约30％至约215％的断裂拉伸应变(标准)和/或约89％的平均断裂拉伸应变。在一个实施例中，膜10具有约430MPa至约750MPa的自动杨氏模量和/或约590MPa的平均自动杨氏模量。膜10的特征在于以上性质中的一种或多种的组合。
参考图1A、1B、2和11E，在一些实施例中，膜10包括多个穿孔或孔14。在一个实施例中，孔14使流体能穿过或输送通过膜10(例如当植入活体组织附近时)。在一些实施例中，可能重要的是，要使流体能从套管的一侧流向另一侧(内侧至外侧)，以便例如避免在膜10与医疗装置12之间产生“死空间”。另外，相比于无此类穿孔的套管，穿孔14可有利地在药物或生物制剂从聚合物中渗出时将这些物质更均匀地分布到邻近的组织和骨骼。
可将孔14配置成具有任何尺寸和形状。在一个实施例中，孔14由大致圆柱形的侧壁限定。在一些实施例中，孔14具有带有为向内凸表面的区段的侧壁。在一些实施例中，向内凸表面基本上呈抛物线状。孔14的横截面不必是完美的圆形，并在一些实施例中可以是卵形、椭圆形、星形或菱形。在一些实施例中，孔14延伸到一个或多个顶点。在一个实施例中，此类顶点在使用期间促进膜10中的撕裂(例如，其中薄弱区通过孔产生)。在一个实施例中，孔14从内表面10b完全延伸通过片材12至外表面10a(参见图4C)。在一个实施例中，一个或多个孔14仅部分地延伸通过膜10，以控制药物释放或增加膜10的初始强度。
孔14可被配置成使膜10具有任何所需的孔隙度。在一个实施例中，膜10的孔隙度大于约0.01。在一个实施例中，膜10的孔隙度大于约0.02。在一个实施例中，膜10的孔隙度大于约0.03。在一个实施例中，膜10的孔隙度大于约0.04。在一个实施例中，膜10的孔隙度大于约0.05。在一个实施例中，膜10的孔隙度大于约0.06。在一个实施例中，膜10的孔隙度大于约0.07。在一个实施例中，膜10的孔隙度大于约0.08。在一个实施例中，膜10的孔隙度大于约0.09。在一个实施例中，膜10的孔隙度大于约0.10。在一个实施例中，膜10的孔隙度大于约0.11。在一个实施例中，膜10的孔隙度大于约0.12。在一个实施例中，膜10的孔隙度大于约0.13。在一个实施例中，膜10的孔隙度大于约0.15。在一个实施例中，膜10的孔隙度大于约0.15。在一个实施例中，膜10的孔隙度大于约0.16。在一个实施例中，膜10的孔隙度大于约0.17。在一个实施例中，膜10的孔隙度大于约0.18。在一个实施例中，膜10的孔隙度大于约0.19。在一个实施例中，膜10的孔隙度大于约0.20。
参考图11E，在一个实施例中，孔14具有约0.75mm的直径并间隔开约1.75mm。在一个实施例中，孔14排列成规则的阵列(例如，如图11D所示的对齐的行和列)。在一个实施例中，孔14排列成不规则的阵列。
参考图1A、1B和4C，在一些实施例中，每个孔14紧邻从第一表面10a突起的至少一个升高唇缘14a。围绕每个穿孔14的升高唇缘14a的有益效果可包括为每个穿孔14提供强化或索环，从而相对于无升高唇缘14a的类似穿孔膜有效地增加膜10的机械强度。唇缘14a的有益效果可包括在第一表面10a上的纹理化表面。这种纹理可以是触感方面的优点，或当例如第一表面10a与另一表面接触时用于增加(或减小)膜10的第一表面10a摩擦的优点。在一个实施例中，唇缘14a降低膜10粘附至表面(诸如植入物的金属表面)的趋势，从而使得由膜10制成的套管更容易滑到植入物上。在一个实施例中，唇缘14a作为植入物与膜10之间的支座(stand-off)，从而减小膜10与植入物接触的表面积。
在一个实施例中，第一表面10a包括在所述多个升高的突起唇缘14a之间延伸的邻接平面部分。在一个实施例中，唇缘14a基本上呈撞击坑的外表面的形状。在一个实施例中，唇缘14a包括连续凹形表面。在一个实施例中，唇缘14a包括抛物线状凹形表面。在一个实施例中，一个或多个唇缘14a(或在一些实施例中，每个唇缘14a)具有凹形外表面和相对的凸形内表面，其中任一者或两者呈抛物线形状。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约0.1mm至约1.0mm的边缘。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约0.1mm的边缘。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约0.2mm的边缘。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约0.3mm的边缘。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约0.4mm的边缘。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约0.5mm的边缘。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约0.6mm的边缘。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约0.7mm的边缘。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约0.8mm的边缘。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约0.9mm的边缘。在一个实施例中，唇缘14a各自具有在第一表面10a的邻接平面部分上升高约1.0mm的边缘。
在一个实施例中，由于唇缘14a，第一表面10a具有第一触感，该第一触感不同于(例如，可由穿戴手术手套的外科医生所辨别)无唇缘14a的第二表面10b的第二触感。在一个实施例中，在第一表面10a上的一个或多个区域中的孔14各自由升高唇缘14a界定，而在第一表面10a上的一个或多个其他区域中的孔14则无此界定。在一个实施例中，各升高唇缘14a的高度h4(参见图4C)是均匀的。在一个实施例中，至少一个升高唇缘14a具有与至少另一唇缘14a不同的高度h4。在一个实施例中，一个或多个孔14由在第一表面10a和第二表面10b一者或两者上的唇缘14a界定。实施例(诸如图1A所示的实施例)可包括围绕每个唇缘14的单个连续唇缘14a。相对于任一个孔或在各孔之间，连续唇缘在厚度上可为基本上均匀的和/或在高度上可为基本上均匀的。孔14可以在整个或至少一部分聚合物片材上均匀地间隔开。在其他实施例中，聚合物片材的至少一部分的特征在于以至少两种不同的间距构型间隔开的孔。
在一些实施例中，膜10包含用于在体内递送的一种或多种药物或其他物质。此类药物包括但不限于抗微生物剂、抗纤维化剂、麻醉剂和抗炎剂以及其他类药物，包括生物制剂，诸如蛋白、生长抑制剂等。
在一个实施例中，膜10包含抗生素。所选的抗生素可具有抗整形外科植入物相关感染中所发现的大部分细菌的活性。这些细菌主要包括葡萄球菌和革兰氏阴性菌。
在一个实施例中，所选的药物在制造植入物所需的制造过程中必需稳定。在一个实施例中，膜10包含庆大霉素。硫酸庆大霉素在100℃以上是热稳定的，并对在一些实施例中用于制造过程的有机溶剂(包括DMSO)是稳定的。
参考图4A-4C，在一个实施例中，膜10包含多种离散的洗脱药物组分30。在一个实施例中，膜10被配置成在植入后在不同的时间段洗脱所述多种离散的药物组分30。在一个实施例中，庆大霉素在体内的洗脱是一个两阶段的过程，即一旦膜10接触水或体液后所发生的破裂释放，以及受聚合物的降解速率控制的第二阶段。在一些实施例中，希望在最初植入时存在庆大霉素的初始破裂释放以减少创伤部位的细菌污染，然后在之后的数天至数周期间存在较低水平的庆大霉素释放以抑制任何存活细菌的生长。在一个实施例中，膜10被配置成在膜10已被植入而与活体组织接触后约1周洗脱出在膜10内所含的药物的约60％。在一个实施例中，粒度和聚合物降解速率的组合控制药物释放特征，并产生所需的2阶段释放。在一个实施例中，药物经2至3周的时间段释放。在其他实施例中，药物经较短或较长的时间范围释放。
在一个实施例中，在这两个阶段中释放的药物的相对量受粒度控制。在一个实施例中，药物组分30均匀分布在整个膜10内，并且相比于不接触膜10的表面的药物组分30，接触膜10的表面的任何药物组分30更快地溶解。在一个实施例中，在植入时接触膜10的表面的药物组分30的量被配置成在植入时破裂释放。在一个实施例中，药物组分30的尺寸越大，则与表面接触的药物组分30的比例越高，并且破裂释放越大。为此，药物组分30的尺寸在一个实施例中保持为直径在10微米以下，该直径使破裂释放降至总药物含量的约20至35％。在一个实施例中，药物组分30的直径在20微米以下。
在一个实施例中，膜10被配置成从一个或多个独立层(其中一些可不含药物)递送多种药物。在其他实施例中，膜10可包含多种药物组分，每一种药物组分的特征在于从膜10释放的速率不同，使得第一药物与不同于第二药物的第二释放特征的第一释放特征相关。
参考图3A-11F，示出了在根据本发明的示例性实施例的制造膜10的方法中所用的装置。
在一个实施例中，开发了聚合物膜10的制造方法以制备用作药物递送膜的聚合物膜10。在一个实施例中，膜10是溶剂浇铸的。在一些实施例中，溶剂浇铸方法在膜10的制造中是有利的，该膜包含可能受熔体方法(诸如吹胀薄膜挤塑)的热和剪切所破坏的药物组分30。使用冲压机(例如，利用数百或数千个孔或具有复杂几何形状的孔)制备膜也是耗时且昂贵的。在一些实施例中，首先将溶剂和药物30混合以形成良好分布的悬浮液，然后将聚合物加入溶液中。
在一些实施例中，在此所述的方法允许薄膜10的形成和孔14的形成在单一步骤中进行。在一些实施例中，本文所述的方法使膜10能具有数千个孔14，具有对几何形状和放置的精确控制以及对膜厚度的精确控制。
参考图3A-3G，在一些实施例中，膜10使用模具18浇铸。在一个实施例中，模具18包括从模具18的底部18a延伸的多个突起或柱状体20以形成孔14。在一个实施例中，模具18由注射成型聚丙烯构成。模具可由其他材料制成，包括聚合物(参见图3F)、玻璃、金属(参见图3G)或陶瓷。在一个实施例中，模具18由两种或更多种材料构成。例如，模具18可具有由金属与聚合物涂层制成的基底以降低浇铸膜对模具的粘附性和/或以形成柱状体20。模具中的腔体可通过浇铸方法、压缩模制方法、注塑方法、化学蚀刻方法或机加工方法形成。
在一个实施例中，模具18包括约0.25mm的腔体深度。在一个实施例中，从模具18a的底部到所述多个柱状体20中的每一个的顶部的距离等于腔体深度(即周壁22的高度)，反之亦然。在一个实施例中，柱状体20长于膜10的所需厚度。在一个实施例中，柱状体20从模具18a的底部延伸0.3mm。在一个实施例中，柱状体20从模具18a的底部延伸0.2mm。在一个实施例中，柱状体20从模具18a的底部延伸0.25mm。在一个实施例中，柱状体20从模具18a的底部延伸0.3mm。在一个实施例中，柱状体20从模具18a的底部延伸0.35mm。在一个实施例中，柱状体20从模具18a的底部延伸0.4mm。在一个实施例中，柱状体20从模具18a的底部延伸0.45mm。在一个实施例中，柱状体20从模具18a的底部延伸0.5mm。
在一个实施例中，柱状体20被布置成产生上述孔14的所选尺寸、形状、图案和布置。在一个实施例中，围型体或周壁22限定总模具面积，并且所述多个柱状体20所限定的面积基本上等于或对应于膜10的开孔面积。
在一个实施例中，模具18包括槽24，其至少部分地围绕模具18的周壁22延伸。在一个实施例中，槽24围绕模具18的整个周壁22延伸。在一些实施例中，槽24保持任何流动或被促动经过周壁22的过量聚合物。在一个实施例中，模具18包括从模具18的至少一个外边缘横向延伸的延伸部40。在一个实施例中，提供延伸部40以抓持和操纵模具18而不与模具18内的聚合物溶液接触。
在一个实施例中，形成用于添加到模具18的聚合物溶液28。在一个实施例中，将聚合物材料在升高的温度下以4:1的溶剂与聚合物比率溶解在二甲基亚砜(DMSO)中并以13重量％添加药物硫酸庆大霉素。在一个实施例中，聚合物溶液28通过在低于90℃的温度下将药物单元30引入聚合物/溶剂共混物而形成。在一个实施例中，聚合物溶液28包含可交联的预聚物，诸如聚氨酯、聚富马酸酯、聚甲基丙烯酸酯等。
参考图4A、6和8，一旦制备好聚合物溶液28后，即将聚合物溶液28置于单面模具18中。在一些实施例中，聚合物溶液28的粘度和/或柱状体20的密度显著地抑制聚合物28在无外力下流遍模具18。在一个实施例中，在向模具18添加聚合物溶液28后，聚合物溶液28的顶部表面是在模具18的基部18a以上的高度h2，其大于模具腔体和柱状体20的高度h1。
参考图4B、7和9，在向模具18添加聚合物溶液28后，在一个实施例中，使用促动装置26以促动聚合物溶液围绕所述多个柱状物20中的每一个。在一个实施例中，促动装置26包括滑动的刀片、条、橡皮扫帚或辊，或使模具18相对于促动装置26移动横跨围型体22和柱状体20的顶部以迫使聚合物溶液28围绕柱状体20流动并流遍整个模具18，使得聚合物溶液28具有基本上均匀的厚度。在一个实施例中，将促动装置26拉引横跨模具18会使过多的材料从柱状体20的顶部表面移除。在一个实施例中，每个柱状体20的外表面在拉引后基本上不含聚合物溶液28。
参考图4C，一旦使聚合物溶液28拉引横跨或遍布整个模具18，则使聚合物溶液28固化以形成膜10。在一个实施例中，将模具18置于升高的温度下的溶剂干燥炉中以移除溶剂，从而留下薄的浇铸膜。在一个实施例中，聚合物溶液28通过向聚合物溶液28施加UV辐射、温度改变、聚合催化剂、可溶性交联剂或它们的组合以使聚合物交联而固化。在一个实施例中，固化步骤包括将包含聚合物溶液28的模具18暴露于第二溶剂。在一个例如聚合物溶液28包含聚合物、药物和第一溶剂的实施例中，第一溶剂可溶于第二溶剂，但聚合物和药物组分不可溶于第二溶剂。因此，通过将聚合物溶液28暴露于第二溶剂，第一溶剂被从聚合物溶液中移除，从而留下聚合物和药品以固化而形成例如膜。
在一个实施例中，固化聚合物溶液将聚合物溶液的厚度从厚度h1降至厚度h3。在一个实施例中，固化聚合物溶液将在柱状体20近侧的聚合物溶液的厚度从厚度h1降至厚度h4。在一个实施例中，在柱状体20近侧的膜10的厚度h4大于在柱状体20之间的膜10的厚度h1。在一个实施例中，唇缘14a通过聚合物溶液在聚合物溶液28固化成膜10期间在柱状体20中的每一个的周围形成弯月面而形成。在一个实施例中，弯月面或唇缘14a与模具18的高度或深度h1具有大约相同的高度h4。在一个实施例中，唇缘14a的高度h4可以通过小心选择柱状体20的材料和几何形状或通过用例如润滑材料诸如含氟聚合物或硅树脂脱模剂涂布柱状体20来控制。在一个实施例中，唇缘14a的高度h4通过聚合物溶液的浓度控制。
参考图10，一旦聚合物溶液28固化后，则将模具18和膜从炉中取出，使之冷却，并将浇铸的穿孔膜10从模具18剥离。
参考图5-7，膜10的制备方法可包括自动化或部分自动化的浇铸机42。在一个实施例中，自动化的浇铸设备包括具有一个或多个处理器和存储器(例如一个或多个非易失性存储装置)的一台或多台计算机44。在一些实施例中，存储器或存储器的计算机可读存储介质存储处理器的程序、模块和数据结构或其子集以控制和运行本文所公开的各种系统和方法。在一个实施例中，计算机可读存储介质在其上存储有计算机可执行指令，该指令在由处理器执行时执行本文所公开的方法中的一种或多种。
膜10可通过其它方法制造。在一个实施例中，可将聚合物溶液28浇铸到具有背衬吸收层的穿孔膜材料上，然后将穿孔膜从吸收层移除，从而移除浇铸溶液，其中在浇铸片材中存在孔。这种方法与上述方法的一个差异在于：在一些实施例中，不在孔14的周围形成升高唇缘。
在另一个实施例中，多孔膜也可通过冻干或冷冻干燥方法形成。在一个实施例中，将聚合物溶液的薄固体膜浇铸在模具中，然后将模具冷冻至低于溶液的冰点的温度，然后置于真空下以从膜中移除溶剂。在一些实施例中，该方法还将产生远小于上文一些实施例中所述的细孔。
在一个实施例中，用于形成浇铸膜的聚合物材料可以是可交联的预聚物液体，将其浇铸到如所本文述的膜模具中，滚压以填充模具并移除多余的材料，然后在原位通过UV辐射、温度、催化剂或其他方式交联。在一个实施例中，该方法可产生与如上所述的非常相似的最终产品，不同的是浇铸膜的最终厚度将会接近或等同于模具深度，并且在孔14的周围将会存在很少的或不存在弯月面或唇缘14a。
在另一个实施例中，可以通过丝网印刷方法形成薄多孔膜。在一个实施例中，以最终图案进行溶液层的丝网印刷，然后干燥。在一个实施例中，这产生非常薄的层，然而可一层接一层地丝网印刷并干燥多个聚合物层，以构造所需的膜厚度。
在另一个实施例中，可如上述，使用具有由疏水性聚合物(诸如硅树脂)以所需穿孔形状制成的图案的玻璃板进行相似的浇铸方法。在一个实施例中，当将薄的聚合物溶液层浇铸到板上时，在玻璃与图案化聚合物之间的表面张力差使溶液在玻璃表面上浓缩，并从图案化疏水性聚合物表面拉离。在一个实施例中，然后将溶液干燥以形成具有与硅树脂聚合物相同图案的穿孔的固体膜。在一个实施例中，也可利用如上所述的可交联预聚物液体进行此方法。
在另一个实施例中，使用双面模具制备薄的多孔聚合物膜，其中将聚合物溶剂溶液注入模具中，并冷冻以固化溶液。在一个实施例中，然后将模具打开并将一面移除，从而在腔体面中留下冷冻溶液。在一个实施例中，将冷冻溶液侧置于炉中以干燥聚合物溶液并形成膜10。
参考图2和11A-11D，在产生膜10后，将膜10成形并形成所需的形式。在一个实施例中，将膜10成形并形成通常符合医疗装置12的尺寸和形状。在一些实施例中，将膜10成形并形成鞘管或套管32、34、36、38。
参考图11A-11F，套管32、34、36、38包括被配置成将膜10形成鞘管的至少一个接缝16。在一个实施例中，套管32、34、36、38通过围绕外周边将第一膜10附接至第二膜10而形成。在一个实施例中，将膜10折叠并至少部分地固定到其本身。例如，可将膜10成形为圆柱体以接合两个相对的边缘。在一个实施例中，第二表面10b与第一表面10a重叠以形成接缝16。在一个实施例中，第二表面10b与第二表面10b重叠以形成接缝16。在一个实施例中，接缝16通过加热膜10的重叠部分并使之再固化而固定。在一个实施例中，套管32、34、36、38的两个端部仍开放以供医疗装置12的插入。在一个实施例中，一个或多个端部是封闭的。在一个实施例中，聚合物片材在形成套管32、34、36、38之前首先形成所需的尺寸和形状。
除了套管32、34、36、38之外，膜10在一些实施例中还可用于其他医疗应用，诸如疝修复网、粘连屏障、软组织填充、过滤膜、药物递送膜、骨移植物固定(例如，在例如脊柱融合术或在长骨的节段性缺损移植中使骨移植物保持就位)或伤口护理产品，诸如绷带。
实例1：
在一个示例性实施例中，植入物通过植入绵羊体内而进行测试。植入物为金属板，其中将管状、薄(0.05-0.08mm)而透明的聚合物套管在即将通过外科手术插入并附接到骨骼前小心地滑动到金属板上。套管紧密配合，在整个长度上完全覆盖金属板，然而套管在板的两个端部是开放的。套管由合成的共聚酯(乙交酯、己内酯、三亚甲基碳酸酯、丙交酯)构成，1.5mm直径的穿孔在整个套管中等距间隔开。一组套管包含1％浓度的三氯生(2,4,4’-三氯-2’-羟基二苯醚)，一组套管包含10％浓度的庆大霉素，并且一组套管包含三氯生(1％)和庆大霉素(10％)的组合。基于体外测试选择庆大霉素和三氯生的浓度以测定每种化合物的治疗窗。
疏水性三氯生在聚合物内为完全溶液形式，与亲水性庆大霉素相反，庆大霉素仍以10-20μm的小粒子悬浮。体外测试已表明，由于三氯生的水中溶解性较差，伴随微弱的初始破裂释放，其在1至3周期间仅缓慢地从这些膜释放。
暴露于套管的表面的水溶性更高的庆大霉素的约50％在插入后24小时内释放到相邻组织中。包封在聚合物深处的其余的庆大霉素更缓慢地溶解并在植入后2至3周的期间释放。聚合物被设计成在手术后60天内通过水解作用而降解。
包含或不包含抗微生物剂的套管经证实是生物相容性的，对软组织和骨愈合的影响甚微并且对金属植入物不具腐蚀性。实验的额外细节可见于Vet Surg.，2012年1月12日，Biodegradable Sleeves for Metal Implants toPrevent Implant-Associated Infection:An Experimental In Vivo Study in Sheep.von Plocki SC,Armbruster D,Klein K,Zlinszky K,Hilbe M,KronenP,GruskinE,von Rechenberg B.，该参考文献全文据此以引用的方式并入。
实例2：
在一个示例性实施例中，膜10通过以下方法制造：
庆大霉素含水量的测定：
硫酸庆大霉素粉末的含水量通过干燥失重方法测量。在玻璃罐中称取约0.5克的庆大霉素，然后在真空下加热到110℃维持3小时，然后再次称重。将重量损失记录为含水量，将其用于计算水分百分比。
溶液混合：
称取14.69克的硫酸庆大霉素粉末，以补偿如上所计算的含水量百分比。使用桨式搅拌器将其在1升的容器内混合到400g的DMSO溶剂中。将混合物搅拌30分钟，直到庆大霉素均匀分布。将100克的包含乙醇酸、己内酯、乳酸和三亚甲基碳酸酯单体的共聚物添加至悬浮液，并将混合容器加热到65℃。持续混合2小时，直至聚合物完全溶入溶液，然后将溶液温度降至55℃。
膜浇铸和溶剂干燥：
使用浇铸模具以及由高密度聚乙烯制成的拉引刀片来从聚合物溶液浇铸薄的穿孔膜。使用碱性洗涤剂溶液预先清洗浇铸模具和拉引刀片，并装载到自动化CNC浇铸夹具中。将15毫升的聚合物溶液抽入聚丙烯注射器中，将注射器装载到浇铸夹具中。浇铸夹具将溶液自动分配到浇铸模具上，并将刀片拉引横跨模具的表面。将填充了聚合物溶液的模具放入85℃下的溶剂干燥炉中约90分钟以使膜干燥。将模具从干燥炉中取出并在2分钟内将膜从模具剥离。
套管密封：
使用具有专门成形的模具的脉冲热密封压机来密封并将浇铸膜切成套管形状。将两个浇铸膜放入压机中，然后将压机以80psi的压力关闭并加热至200℃下维持4秒。将套管从过量的膜材料移除并切成合适的长度。可将密封的套管在50℃下真空干燥并密封在防水包装物中以防止生物吸收性聚合物降解。
本领域的技术人员将认识到，在不脱离本发明的广义发明构思的情况下，可对上文所示和所述的示例性实施例作出修改。因此，应当理解，本发明不限于所示和所述的示例性实施例，而是旨在涵盖如权利要求书所限定的本发明的实质和范围内的修改。例如，示例性实施例的具体特征可以是或可以不是受权利要求书保护的发明的一部分，并且可将所公开的实施例的特征加以组合。除非在本文具体示出，否则术语“一个/种”和“该/所述”不限于一个元件，而相反应被解读为意指“至少一个/种”。
应当理解，为清楚理解本发明，本发明的附图和说明中的至少一些已经简化以专注于相关的元件，同时为清楚起见，省去本领域普通技术人员将认识到也可构成本发明一部分的其他元件。然而，由于此类元件是本领域熟知的，并且由于它们不必然地有利于更好地理解本发明，所以本文不提供对此类元件的说明。
另外，在方法不依赖于本文所示的步骤的特定顺序的程度上，步骤的特定顺序不应视为对权利要求书的限制。涉及本发明方法的权利要求不应限于以书写的顺序执行其步骤，并且本领域的技术人员可容易地认识到这些步骤可以变化并仍在本发明的实质和范围内。

Claims (28)

1. 一种柔性体，包括：
具有第一表面和相对的第二表面的聚合物膜，所述聚合物膜具有从所述第一表面延伸到所述第二表面的多个孔以及从所述第一表面突起的多个升高唇缘，使得所述多个孔中的每一个被所述多个升高唇缘中的一个围绕。
2. 根据权利要求1所述的柔性体，其中所述聚合物膜包含生物吸收性聚合物。
3. 根据权利要求2所述的柔性体，其中所述生物吸收性聚合物包含选自以下的重复单元：L-乳酸、D-乳酸、L-丙交酯、D-丙交酯、D,L-丙交酯、乙交酯、内酯、内酰胺、三亚甲基碳酸酯、环状碳酸酯、环醚、对二氧环己酮、β-羟基丁酸、β-羟基丙酸、β-羟基戊酸，以及它们的组合。
4. 根据权利要求2所述的柔性体，其中所述生物吸收性聚合物包含选自以下的重复单元：L-乳酸、D-乳酸、L-丙交酯、D-丙交酯、D,L-丙交酯、ε-己内酯、三亚甲基碳酸酯、对二氧环己酮，以及它们的组合。
5. 根据权利要求2所述的柔性体，其中所述生物吸收性聚合物是乙交酯、三亚甲基碳酸酯、丙交酯和己内酯的共聚物。
6. 根据权利要求1所述的柔性体，其中所述第一表面包括在所述多个升高唇缘之间延伸的邻接平面部分。
7. 根据权利要求6所述的柔性体，其中所述多个升高唇缘各自具有比所述邻接平面部分高约0.1mm至约1.0mm的外边缘。
8. 根据权利要求1所述的柔性体，其中所述聚合物膜包含多种离散的洗脱药物组分，并且其中所述聚合物膜被配置成在植入所述柔性体后在不同时间段洗脱所述多种离散的药物组分。
9. 根据权利要求1所述的柔性体，还包括被配置成将所述聚合物膜形成鞘管的至少一个接缝。
10. 根据权利要求1所述的柔性体，其中所述聚合物膜在第一平面方向上具有第一拉伸强度并在垂直于所述第一平面方向的第二平面方向上具有第二拉伸强度，其中所述第一拉伸强度基本上等于所述第二拉伸强度。
11. 根据权利要求1所述的柔性体，其中所述聚合物膜具有不大于0.06mm的标称厚度。
12. 根据权利要求1所述的柔性体，其中所述第一表面具有不同于所述第二表面的第二触感的第一触感。
13. 一种制备聚合物膜的方法，包括：
将聚合物溶液置于具有从模具的底部延伸的多个突起的单面模具中，其中所述聚合物溶液的特征在于抑制所述聚合物无外力流遍所述模具的粘度；
促动所述聚合物溶液围绕所述多个突起中的每一个；以及
固化所述聚合物溶液。
14. 根据权利要求13所述的方法，其中所述模具包括延伸高度基本上等于所述多个突起中的每一个的高度的围型体。
15. 根据权利要求14所述的方法，其中所述促动包括拉引促动装置横跨所述围型体和所述多个突起，以迫使所述聚合物溶液围绕所述多个突起流动并流遍所述模具，使得所述聚合物溶液具有基本上均匀的厚度。
16. 根据权利要求15所述的方法，其中所述突起中的每一个的外表面在所述拉引后基本上不含聚合物溶液。
17. 根据权利要求14所述的方法，其中所述放置步骤包括将所述聚合物溶液沉积在所述模具中，使得所述聚合物溶液的一部分在所述围型体和所述突起的高度以上。
18. 根据权利要求13所述的方法，其中所述聚合物溶液包含药物。
19. 根据权利要求18所述的方法，其中所述聚合物溶液通过在低于90℃的温度下混合溶剂、聚合物和所述药物而形成。
20. 根据权利要求18所述的方法，其中所述药物包括离散的药物单元。
21. 根据权利要求13所述的方法，其中固化所述聚合物溶液包括减小所述聚合物溶液的厚度。
22. 根据权利要求13所述的方法，其中固化所述聚合物溶液包括围绕所述多个突起中的每一个形成固化聚合物的弯月面。
23. 根据权利要求13所述的方法，其中从所述模具的底部到所述多个突起中的每一个的顶部的距离小于约0.3mm。
24. 根据权利要求13所述的方法，其中所述围型体限定总模具面积并且所述多个突起限定所述总模具面积的至少约15%的面积。
25. 根据权利要求13所述的方法，还包括将所述药物洗脱膜从所述模具剥离。
26. 根据权利要求13所述的方法，其中所述聚合物溶液包括可交联的预聚物溶液。
27. 根据权利要求13所述的方法，其中所述固化步骤包括通过向所述聚合物溶液施加UV辐射、温度改变、聚合催化剂、可溶性交联剂或它们的组合而交联所述聚合物。
28. 根据权利要求13所述的方法，其中所述聚合物溶液包含第一溶剂和聚合物，并且所述固化步骤包括将所述聚合物溶液暴露于第二溶剂，在所述第二溶剂中，所述第一溶剂是可溶的并且所述聚合物和所述药物是不可溶的，使得所述第一溶剂至少基本上从所述聚合物溶液中移除，并且所述聚合物固化以包含所述药物。
CN201280070872.4A 2011-12-28 2012-12-27 膜及制造方法 Active CN104135954B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161580679P 2011-12-28 2011-12-28
US61/580679 2011-12-28
US61/580,679 2011-12-28
PCT/US2012/071708 WO2013101867A1 (en) 2011-12-28 2012-12-27 Films and methods of manufacture

Publications (2)

Publication Number Publication Date
CN104135954A true CN104135954A (zh) 2014-11-05
CN104135954B CN104135954B (zh) 2017-11-07

Family

ID=47557536

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280070872.4A Active CN104135954B (zh) 2011-12-28 2012-12-27 膜及制造方法

Country Status (11)

Country Link
US (3) US9381683B2 (zh)
EP (2) EP2797530B1 (zh)
JP (1) JP6342330B2 (zh)
KR (1) KR102127615B1 (zh)
CN (1) CN104135954B (zh)
AU (1) AU2012362432B2 (zh)
BR (1) BR112014016086A8 (zh)
CA (1) CA2862343C (zh)
RU (1) RU2630544C2 (zh)
TW (1) TWI590843B (zh)
WO (1) WO2013101867A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101420988B1 (ko) 2005-10-13 2014-07-17 신세스 게엠바하 약물-함침 용기
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
DE102013208924A1 (de) * 2013-05-14 2014-12-04 Johnson & Johnson Medical Gmbh Chirurgisches Implantat umfassend einer Lage mit Öffnungen
CA2916249C (en) 2013-06-21 2021-07-13 DePuy Synthes Products, Inc. Films and methods of manufacture
JP2018504980A (ja) * 2015-02-16 2018-02-22 テクレス・ソシエタ・ペル・アチオニＴｅｃｒｅｓ Ｓ．Ｐ．Ａ． 人体内に埋め込まれる装置用および関節スペーサ用のプラスチック材料
US10881762B2 (en) * 2017-11-15 2021-01-05 De Novo Orthopedics Inc. Method for manufacturing bioinductive patch
JP7290302B2 (ja) * 2018-10-26 2023-06-13 国立研究開発法人農業・食品産業技術総合研究機構 ハイドロゲル膜及びその使用
WO2020205913A1 (en) * 2019-04-03 2020-10-08 University Of Central Florida Research Foundation, Inc. Frozen, porous thin films and methods of making and use thereof
CO2020003883A1 (es) 2020-03-30 2021-04-08 Techfit Digital Surgery Inc Placa de osteosíntesis trabecular a la medida del paciente con recubrimiento antibiótico
CN112109259B (zh) * 2020-09-04 2022-04-15 杭州俊为科技有限责任公司 一种薄膜及其制备技术

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3719736A (en) * 1970-10-08 1973-03-06 Gen Foods Corp Method of producing perforated plastic film
US5326356A (en) * 1990-06-01 1994-07-05 Fidia S.P.A. Biocompatible perforated membranes, processes for their preparation, their use as a support in the in vitro growth of epithelial cells, the artificial skin obtained in this manner, and its use in skin grafts
CN1130175C (zh) * 1994-06-30 2003-12-10 普罗克特和甘保尔公司 具有表面能量梯度的絮网、絮网制造方法和吸湿用品
CN101437571A (zh) * 2005-10-13 2009-05-20 斯恩蒂斯有限公司 载药包装物
US20090192609A1 (en) * 2008-01-29 2009-07-30 Zimmer, Inc. Implant device for use in an implant system
US20110268781A1 (en) * 2009-11-09 2011-11-03 Gore Enterprise Holdings, Inc. Drug eluting composite

Family Cites Families (309)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1181333A (fr) * 1957-08-20 1959-06-15 Comp Generale Electricite Appareil permettant de déceler si un point d'une installation électrique est sous tension, et de vérifier la concordance de phase entre les tensions en deux points deladite installation
FR1183333A (fr) 1957-09-25 1959-07-06 Omniplast Procédé de fabrication, par coulage, d'articles pelliculaires, en matière plastique et, en particulier, d'articles pelliculaires ajourés
US3155095A (en) 1961-02-07 1964-11-03 Adolph M Brown Anastomosis method and means
US3949037A (en) * 1972-09-14 1976-04-06 Dacor, Incorporated Method of making a simulated brick having a configured undercut face and a reverse surface having a sharp upstanding peripheral edge
US4148871A (en) 1977-10-11 1979-04-10 Pitt Colin G Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers
SU683207A1 (ru) * 1977-12-27 1985-03-07 Предприятие П/Я А-7924 Способ получени сшитого полиметилметакрилата
DE2806609C2 (de) 1978-02-16 1980-03-13 Anton Dr. 4400 Muenster Haerle Osteosynthesehilfsmittel
FR2445763A1 (fr) 1979-01-03 1980-08-01 Hureau Jean Claude Procede pour l'extrusion d'une gaine thermoplastique sous forme d'un film tubulaire pourvu de perforations et dispositif pour la mise en oeuvre du procede
CA1190855A (en) 1980-09-03 1985-07-23 Rolf W. Pfirrmann Treatment of osteitis
US4605730A (en) 1982-10-01 1986-08-12 Ethicon, Inc. Surgical articles of copolymers of glycolide and ε-caprolactone and methods of producing the same
US4774091A (en) 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4659700A (en) 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
US4605414A (en) 1984-06-06 1986-08-12 John Czajka Reconstruction of a cruciate ligament
DE3445738A1 (de) 1984-12-14 1986-06-19 Draenert Klaus Implantat zur knochenverstaerkung und verankerung von knochenschrauben, implantaten oder implantatteilen
DE3533369A1 (de) 1985-09-19 1987-03-19 Alois Prof Dr Med Bloemer Antibioticahaltiges mittel und seine verwendung als chirurgisches kunststoffmaterial
JPH0824347B2 (ja) 1986-05-12 1996-03-06 松下電器産業株式会社 カラーテレビジョンカメラ用輪郭補正器
US4730726A (en) 1987-04-21 1988-03-15 United States Surgical Corporation Sealed sterile package
DE3800259A1 (de) * 1988-01-05 1989-07-13 Mecron Med Prod Gmbh Implantierbare prothese
US4888023B1 (en) 1988-01-19 1996-01-23 Osteonics Corp Femoral prosthesis with uncoupled distal tip
US5100668A (en) 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
DE3831657A1 (de) 1988-09-17 1990-03-22 Boehringer Ingelheim Kg Vorrichtung zur osteosynthese und verfahren zu ihrer herstellung
ES2075063T3 (es) 1988-11-30 1995-10-01 Nihon Tokkyo Kanri Co Ltd Peliculas separables.
US5147400A (en) 1989-05-10 1992-09-15 United States Surgical Corporation Connective tissue prosthesis
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
JPH0385179A (ja) 1989-08-30 1991-04-10 Sumitomo Bakelite Co Ltd 医療用バルーンカテーテル
US5268178A (en) 1989-09-25 1993-12-07 The Board Of Regents, The University Of Texas System Biodegradable antibiotic implants and methods of their use in treating and preventing infections
US5093319A (en) 1989-10-31 1992-03-03 Pfizer Hospital Products Group, Inc. Use of derivatives of chitin soluble in aqueous solutions for preventing adhesions
DE3939363A1 (de) * 1989-11-29 1991-06-06 Aesculap Ag Verfahren zur herstellung von koerperimplantaten aus resorbierbarem kunststoffmaterial
DE4010051C1 (zh) 1990-03-29 1991-08-08 Upat Gmbh & Co, 7830 Emmendingen, De
US5281221A (en) 1990-12-05 1994-01-25 Tadych Kevin L Antimicrobial device for use in external fixators
JPH04221538A (ja) 1990-12-21 1992-08-12 Olympus Optical Co Ltd 穿刺装置
GB2251795B (en) 1991-01-17 1995-02-08 Minnesota Mining & Mfg Orthopaedic implant
FR2673843B1 (fr) * 1991-03-14 1995-01-13 Centre Nat Rech Scient Composition pharmaceutique implantable, bioresorbable a base de poly(acide lactique), destinee a mettre en óoeuvre une antibiotherapie interne locale.
AU666118B2 (en) 1991-04-25 1996-02-01 Brown University Research Foundation Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
US5800829A (en) 1991-04-25 1998-09-01 Brown University Research Foundation Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
FR2678823B1 (fr) 1991-07-11 1995-07-07 Legrand Jean Jacques Dispositif de renforcement d'un ligament au cours d'une plastie ligamentaire.
EP0523926A3 (en) 1991-07-15 1993-12-01 Smith & Nephew Richards Inc Prosthetic implants with bioabsorbable coating
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
US5571193A (en) 1992-03-12 1996-11-05 Kampner; Stanley L. Implant with reinforced resorbable stem
US6071567A (en) 1992-03-25 2000-06-06 Reeves Brothers, Inc. Formation of compressible ply containing high melting point thermoplastic microspheres and printing blankets comprising same
US7101392B2 (en) 1992-03-31 2006-09-05 Boston Scientific Corporation Tubular medical endoprostheses
EP0633798B1 (en) 1992-03-31 2003-05-07 Boston Scientific Corporation Vascular filter
US6497709B1 (en) 1992-03-31 2002-12-24 Boston Scientific Corporation Metal medical device
US5955095A (en) 1992-04-22 1999-09-21 Brown University Research Foundation Microporous macrocapsules
US5383928A (en) 1992-06-10 1995-01-24 Emory University Stent sheath for local drug delivery
US5521193A (en) 1992-06-24 1996-05-28 G. D. Searle & Co. Benzimidazole compounds
JPH0744936Y2 (ja) 1992-06-29 1995-10-11 サンデン株式会社 ショーケースの排水構造
DE4222380A1 (de) 1992-07-08 1994-01-13 Ernst Peter Prof Dr M Strecker In den Körper eines Patienten perkutan implantierbare Endoprothese
EP0674497B1 (en) 1992-11-16 2002-07-24 Brown University Research Foundation Microporous macrocapsules
YU48736B (sh) 1992-12-16 1999-09-27 Milorad prof. dr. Mitković Uređaj za spoljnu fiksaciju kostiju
US5468253A (en) 1993-01-21 1995-11-21 Ethicon, Inc. Elastomeric medical device
CA2114290C (en) 1993-01-27 2006-01-10 Nagabushanam Totakura Post-surgical anti-adhesion device
US5716981A (en) 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
ATE241327T1 (de) 1993-09-14 2003-06-15 Lanny L Johnson Biologischer bandersatz
WO2003059213A2 (en) 1994-01-26 2003-07-24 Kyphon Inc. Inflatable device for use in surgical protocol relating to fixation of bone
US6716216B1 (en) 1998-08-14 2004-04-06 Kyphon Inc. Systems and methods for treating vertebral bodies
US20030032963A1 (en) 2001-10-24 2003-02-13 Kyphon Inc. Devices and methods using an expandable body with internal restraint for compressing cancellous bone
US5656605A (en) 1994-01-26 1997-08-12 Institute Of Molecular Biology, Inc. Device to promote drug-induced nerve regeneration
US6241734B1 (en) 1998-08-14 2001-06-05 Kyphon, Inc. Systems and methods for placing materials into bone
US6248110B1 (en) 1994-01-26 2001-06-19 Kyphon, Inc. Systems and methods for treating fractured or diseased bone using expandable bodies
US5507814A (en) 1994-03-30 1996-04-16 Northwestern University Orthopedic implant with self-reinforced mantle
US6165210A (en) 1994-04-01 2000-12-26 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
US6001123A (en) 1994-04-01 1999-12-14 Gore Enterprise Holdings Inc. Folding self-expandable intravascular stent-graft
US5947893A (en) 1994-04-27 1999-09-07 Board Of Regents, The University Of Texas System Method of making a porous prothesis with biodegradable coatings
DE4414675C1 (de) 1994-04-27 1995-09-28 Kirsch Axel Abdeckeinrichtung für Knochendefektstellen und Verfahren zu deren Herstellung
CA2189006A1 (en) 1994-04-29 1995-11-09 David L. Sandock Medical prosthetic stent and method of manufacture
EP0754017B1 (en) 1994-04-29 2002-06-19 SciMed Life Systems, Inc. Stent with collagen
US20030086975A1 (en) * 2001-11-08 2003-05-08 Timothy Ringeisen Method for making a porous Polymeric material
JP3125579B2 (ja) 1994-05-24 2001-01-22 三菱マテリアル株式会社 生体用セメント充填装置
JP3250127B2 (ja) 1994-07-14 2002-01-28 三菱マテリアル株式会社 生体用セメント注入治具
DE4424883A1 (de) 1994-07-14 1996-01-18 Merck Patent Gmbh Femurprothese
US6331188B1 (en) 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
US6015429A (en) 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US5489305A (en) 1994-10-03 1996-02-06 Timesh, Inc. Mandibular prostheses
WO1996016612A1 (en) 1994-12-02 1996-06-06 Omeros Medical Systems, Inc. Tendon and ligament repair system
US5637113A (en) 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
IL116433A (en) 1994-12-19 2002-02-10 Galen Chemicals Ltd INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
US5612052A (en) 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US6060640A (en) * 1995-05-19 2000-05-09 Baxter International Inc. Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
DE59511075D1 (de) 1995-11-08 2007-02-08 Zimmer Gmbh Vorrichtung zum Einbringen eines Implantats, insbesondere einer Zwischenwirbelprothese
CN1206353A (zh) 1995-11-21 1999-01-27 E·N·勒纳 提高有机体内生物活性物质和化合物释放的装置
JPH09201330A (ja) 1996-01-25 1997-08-05 Nissho Corp ドレナージチューブ組立体
FR2745710B1 (fr) 1996-03-11 1998-05-29 Rippstein Pascal Francois Dispositif passe-tendon
DE19646212A1 (de) 1996-11-08 1998-05-14 Pelikan Scotland Ltd Mehrschichtiger Verbundkörper
US5755720A (en) 1997-01-03 1998-05-26 Mikhail Michael W E Method and apparatus for performing hip prosthesis surgery
US5713904A (en) 1997-02-12 1998-02-03 Third Millennium Engineering, Llc Selectively expandable sacral fixation screw-sleeve device
AUPO530997A0 (en) 1997-02-25 1997-03-20 Esnouf, Philip Stuart Surgical aid for connective tissue grafting and method for employing same
WO1998051240A1 (en) 1997-05-15 1998-11-19 Hayes Medical, Inc. Temporary implantable prosthesis
US6306166B1 (en) 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
US6468300B1 (en) 1997-09-23 2002-10-22 Diseno Y Desarrollo Medico, S.A. De C.V. Stent covered heterologous tissue
US6254627B1 (en) 1997-09-23 2001-07-03 Diseno Y Desarrollo Medico S.A. De C.V. Non-thrombogenic stent jacket
US6986788B2 (en) 1998-01-30 2006-01-17 Synthes (U.S.A.) Intervertebral allograft spacer
US7087082B2 (en) 1998-08-03 2006-08-08 Synthes (Usa) Bone implants with central chambers
US6143033A (en) 1998-01-30 2000-11-07 Synthes (Usa) Allogenic intervertebral implant
USRE38614E1 (en) 1998-01-30 2004-10-05 Synthes (U.S.A.) Intervertebral allograft spacer
US5984926A (en) 1998-02-24 1999-11-16 Jones; A. Alexander M. Bone screw shimming and bone graft containment system and method
US6494898B1 (en) 1998-02-25 2002-12-17 United States Surgical Corporation Absorbable copolymers and surgical articles fabricated therefrom
WO1999049819A1 (en) 1998-04-01 1999-10-07 Parallax Medical, Inc. Pressure applicator for hard tissue implant placement
WO1999051171A1 (en) * 1998-04-07 1999-10-14 Macropore, Inc. Membrane with tissue-guiding surface corrugations
US6280411B1 (en) 1998-05-18 2001-08-28 Scimed Life Systems, Inc. Localized delivery of drug agents
WO1999062416A1 (en) 1998-06-01 1999-12-09 Kyphon Inc. Expandable preformed structures for deployment in interior body regions
US6719773B1 (en) 1998-06-01 2004-04-13 Kyphon Inc. Expandable structures for deployment in interior body regions
US6165202A (en) 1998-07-06 2000-12-26 United States Surgical Corporation Absorbable polymers and surgical articles fabricated therefrom
DE69916280T2 (de) 1998-08-03 2005-05-25 Synthes Ag Chur, Chur Zwischenwirbel-allotransplantat-distanzstück
CA2338788A1 (en) 1998-09-02 2000-03-09 Scimed Life Systems, Inc. Drug delivery device for stent
US6350284B1 (en) 1998-09-14 2002-02-26 Bionx Implants, Oy Bioabsorbable, layered composite material for guided bone tissue regeneration
US6248112B1 (en) 1998-09-30 2001-06-19 C. R. Bard, Inc. Implant delivery system
US6235869B1 (en) 1998-10-20 2001-05-22 United States Surgical Corporation Absorbable polymers and surgical articles fabricated therefrom
US6117442A (en) 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens
US6063395A (en) 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6884427B1 (en) 1999-02-08 2005-04-26 Aderans Research Institute, Inc. Filamentary means for introducing agents into tissue of a living host
US6104276A (en) 1999-03-22 2000-08-15 Samsung Electro-Mechanics Co., Ltd. FBT, its bleeder resistor, and device for coupling bleeder resistor
US6221097B1 (en) 1999-03-22 2001-04-24 Scimed Life System, Inc. Lubricated sleeve material for stent delivery
US6331186B1 (en) 1999-03-22 2001-12-18 Scimed Life Systems, Inc. End sleeve coating for stent delivery
US6443980B1 (en) 1999-03-22 2002-09-03 Scimed Life Systems, Inc. End sleeve coating for stent delivery
WO2000057820A1 (en) 1999-03-31 2000-10-05 Stocks Gregory W Joint prosthesis assembly and method for installing same
SE515227C2 (sv) 1999-04-28 2001-07-02 Bruce Medical Ab Kropp för åstadkommande av in- och tillväxt av benvävnad och/ eller bindväv och sätt för framställning av kroppen
IT1307263B1 (it) 1999-08-05 2001-10-30 Sorin Biomedica Cardio Spa Stent per angioplastica con azione antagonista della restenosi,relativo corredo e componenti.
US6596296B1 (en) 1999-08-06 2003-07-22 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US6425919B1 (en) 1999-08-18 2002-07-30 Intrinsic Orthopedics, Inc. Devices and methods of vertebral disc augmentation
US7094258B2 (en) 1999-08-18 2006-08-22 Intrinsic Therapeutics, Inc. Methods of reinforcing an annulus fibrosis
IL155494A0 (en) 1999-08-18 2003-11-23 Intrinsic Therapeutics Inc Devices and method for nucleus pulposus augmentation and retention
US6759054B2 (en) 1999-09-03 2004-07-06 Advanced Cardiovascular Systems, Inc. Ethylene vinyl alcohol composition and coating
US6503954B1 (en) 2000-03-31 2003-01-07 Advanced Cardiovascular Systems, Inc. Biocompatible carrier containing actinomycin D and a method of forming the same
US7682647B2 (en) 1999-09-03 2010-03-23 Advanced Cardiovascular Systems, Inc. Thermal treatment of a drug eluting implantable medical device
US6287628B1 (en) 1999-09-03 2001-09-11 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
US6790228B2 (en) 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US6749626B1 (en) 2000-03-31 2004-06-15 Advanced Cardiovascular Systems, Inc. Actinomycin D for the treatment of vascular disease
US6713119B2 (en) 1999-09-03 2004-03-30 Advanced Cardiovascular Systems, Inc. Biocompatible coating for a prosthesis and a method of forming the same
US6379381B1 (en) 1999-09-03 2002-04-30 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
US6503556B2 (en) 2000-12-28 2003-01-07 Advanced Cardiovascular Systems, Inc. Methods of forming a coating for a prosthesis
CA2389232C (en) 1999-10-29 2008-07-29 Michele Staud Marcolongo Associating hydrogels for nucleus pulposus replacement in intervertebral discs
US6287291B1 (en) 1999-11-09 2001-09-11 Advanced Cardiovascular Systems, Inc. Protective sheath for catheters
US6908624B2 (en) 1999-12-23 2005-06-21 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US6476079B1 (en) 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US6379382B1 (en) 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US20030229393A1 (en) 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
US7698111B2 (en) 2005-03-09 2010-04-13 Hewlett-Packard Development Company, L.P. Method and apparatus for computational analysis
WO2001068158A1 (en) 2000-03-15 2001-09-20 Orbus Medical Technologies Inc. Coating that promotes endothelial cell adherence
US7279008B2 (en) 2000-03-16 2007-10-09 Smith & Nephew, Inc. Sheaths for implantable fixation devices
US6746483B1 (en) 2000-03-16 2004-06-08 Smith & Nephew, Inc. Sheaths for implantable fixation devices
AR027685A1 (es) 2000-03-22 2003-04-09 Synthes Ag Forma de tejido y metodo para realizarlo
US6818247B1 (en) 2000-03-31 2004-11-16 Advanced Cardiovascular Systems, Inc. Ethylene vinyl alcohol-dimethyl acetamide composition and a method of coating a stent
ES2262642T3 (es) 2000-04-05 2006-12-01 Kyphon Inc. Dispositivo para el tratamiento de huesos fracturados y/o enfermos.
US6520984B1 (en) 2000-04-28 2003-02-18 Cardiovasc, Inc. Stent graft assembly and method
US6451050B1 (en) 2000-04-28 2002-09-17 Cardiovasc, Inc. Stent graft and method
US6299894B1 (en) 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
AU2004202878B2 (en) 2000-05-10 2005-12-01 Fisher & Paykel Healthcare Limited Components For Breathing Circuits
BR0102116B1 (pt) * 2000-05-10 2010-09-21 componente para um membro de circuito de respiração.
US7238168B2 (en) 2000-06-02 2007-07-03 Avantec Vascular Corporation Exchangeable catheter
US6569180B1 (en) 2000-06-02 2003-05-27 Avantec Vascular Corporation Catheter having exchangeable balloon
DE60136815D1 (de) 2000-07-14 2009-01-15 Kyphon Inc Vorrichtungen zur behandlung von wirbelkoerpern
US6451003B1 (en) 2000-08-16 2002-09-17 Biolink Corporation Method and apparatus for overcoming infection in a tissue pocket surrounding an implanted device
DE10041684A1 (de) * 2000-08-24 2002-03-07 Inst Textil & Faserforschung Beschichtungsmaterial zur medizinischen Behandlung aus resorbierbarem synthetischem Material, Verfahren zu seiner Herstellung und Verwendung in der Medizin
US7503936B2 (en) 2000-08-30 2009-03-17 Warsaw Orthopedic, Inc. Methods for forming and retaining intervertebral disc implants
US6953560B1 (en) 2000-09-28 2005-10-11 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US6716444B1 (en) 2000-09-28 2004-04-06 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
EP1328203B1 (en) 2000-10-25 2009-11-18 Kyphon SÀRL Systems for reducing fractured bone using a fracture reduction cannula
US6692498B1 (en) 2000-11-27 2004-02-17 Linvatec Corporation Bioabsorbable, osteopromoting fixation plate
US6545097B2 (en) 2000-12-12 2003-04-08 Scimed Life Systems, Inc. Drug delivery compositions and medical devices containing block copolymer
US6599323B2 (en) 2000-12-21 2003-07-29 Ethicon, Inc. Reinforced tissue implants and methods of manufacture and use
US7192604B2 (en) 2000-12-22 2007-03-20 Ethicon, Inc. Implantable biodegradable devices for musculoskeletal repair or regeneration
KR100408458B1 (ko) 2000-12-27 2003-12-06 한국과학기술연구원 생분해성 글리콜라이드/ε-카프로락톤 공중합체로부터 제조된 조직공학용 다공성 지지체
US7504125B1 (en) 2001-04-27 2009-03-17 Advanced Cardiovascular Systems, Inc. System and method for coating implantable devices
US6547812B1 (en) 2000-12-29 2003-04-15 Advanced Cardiovascular Systems, Inc. Radiation therapy using a radioactive implantable device and a radiosensitizer agent
JP4840895B2 (ja) 2001-02-20 2011-12-21 株式会社日本吸収体技術研究所 液体分配ユニットとそれを備えた吸収体製品
US6827743B2 (en) 2001-02-28 2004-12-07 Sdgi Holdings, Inc. Woven orthopedic implants
NL1017672C2 (nl) 2001-03-22 2002-09-24 Hendrik Glastra Implanteerbaar samenstel met therapeutische werking.
US6899994B2 (en) 2001-04-04 2005-05-31 Kodak Polychrome Graphics Llc On-press developable IR sensitive printing plates using binder resins having polyethylene oxide segments
US20050209629A1 (en) 2001-04-19 2005-09-22 Kerr Sean H Resorbable containment device and process for making and using same
US6632235B2 (en) 2001-04-19 2003-10-14 Synthes (U.S.A.) Inflatable device and method for reducing fractures in bone and in treating the spine
WO2002096389A1 (en) 2001-05-30 2002-12-05 Microchips, Inc. Conformal coated microchip reservoir devices
US6592885B2 (en) 2001-06-07 2003-07-15 Matthew D. Phaneuf Method for making infection-resistant fabricated textile articles for biomedical applications
US6666880B1 (en) 2001-06-19 2003-12-23 Advised Cardiovascular Systems, Inc. Method and system for securing a coated stent to a balloon catheter
US7175873B1 (en) 2001-06-27 2007-02-13 Advanced Cardiovascular Systems, Inc. Rate limiting barriers for implantable devices and methods for fabrication thereof
US7247313B2 (en) 2001-06-27 2007-07-24 Advanced Cardiovascular Systems, Inc. Polyacrylates coatings for implantable medical devices
US20050129732A1 (en) 2001-07-13 2005-06-16 Flow Focusing, Inc. Biodegradable, antibiotic, controlled release tape
US20030050644A1 (en) 2001-09-11 2003-03-13 Boucher Ryan P. Systems and methods for accessing and treating diseased or fractured bone employing a guide wire
IN2014DN10834A (zh) 2001-09-17 2015-09-04 Psivida Inc
US7168605B2 (en) 2001-09-18 2007-01-30 Boston Scientific Scimed, Inc. Microtubes for therapeutic delivery
CN2534997Y (zh) 2001-09-21 2003-02-12 钱本文 股骨颈保护装置
US7425292B2 (en) * 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
ATE411058T1 (de) 2001-10-25 2008-10-15 Univ Emory Katheter für modifizierte perfusion
US20030093111A1 (en) 2001-10-26 2003-05-15 Concentric Medical Device for vaso-occlusion and interventional therapy
US20030088307A1 (en) * 2001-11-05 2003-05-08 Shulze John E. Potent coatings for stents
US7182779B2 (en) 2001-12-03 2007-02-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US7294146B2 (en) 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US7351255B2 (en) 2001-12-03 2008-04-01 Xtent, Inc. Stent delivery apparatus and method
US7147656B2 (en) 2001-12-03 2006-12-12 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US7137993B2 (en) 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7270668B2 (en) 2001-12-03 2007-09-18 Xtent, Inc. Apparatus and methods for delivering coiled prostheses
US20030135266A1 (en) 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7309350B2 (en) 2001-12-03 2007-12-18 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
CA2470824A1 (en) 2001-12-21 2003-08-28 Cardiovasc, Inc. Composite stent with polymeric covering and bioactive coating
US6863530B2 (en) 2001-12-28 2005-03-08 Incumed, Inc. Expandable polymer dental implant and method of use
US6840770B2 (en) 2001-12-28 2005-01-11 Mcdevitt Dennis Expandable polymer dental implant and method of use
US7070613B2 (en) 2002-01-04 2006-07-04 Boston Scientific Scimed, Inc. Non-compliant balloon with compliant top-layer to protect coated stents during expansion
US8221482B2 (en) 2002-01-28 2012-07-17 Orbusneich Medical, Inc. Flared ostial endoprosthesis and delivery system
US6790224B2 (en) 2002-02-04 2004-09-14 Scimed Life Systems, Inc. Medical devices
EP1334702B1 (de) 2002-02-08 2004-07-07 Karl Storz GmbH & Co. KG Ankerelement zum Verankern eines Ligamenttransplantates
KR101127502B1 (ko) 2002-03-11 2012-03-23 알콘, 인코퍼레이티드 이식 가능한 약물 전달 시스템
EP1344538A1 (en) 2002-03-14 2003-09-17 Degradable Solutions AG Porous biodegradable implant material and method for its fabrication
US7041308B2 (en) 2002-04-18 2006-05-09 Poly-Med, Inc. Drug-polymer coated stents with segmented homochain copolyesters
US7166130B2 (en) 2002-06-27 2007-01-23 Ferree Bret A Artificial disc replacements with deployable fixation components
US7622146B2 (en) 2002-07-18 2009-11-24 Advanced Cardiovascular Systems, Inc. Rate limiting barriers for implantable devices and methods for fabrication thereof
AU2003259684C1 (en) 2002-07-31 2009-03-26 Mast Biosurgery Ag Apparatus and method for preventing adhesions between an implant and surrounding tissues
US20050019404A1 (en) * 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
JP2006515186A (ja) 2002-09-26 2006-05-25 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 血管周囲ラップ
US6863692B2 (en) 2002-11-14 2005-03-08 Zimmer Technology, Inc. Implant sleeve and method
US7695446B2 (en) 2002-12-02 2010-04-13 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
US7025791B2 (en) 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
US20040106199A1 (en) 2002-12-02 2004-06-03 Eliseev Alexey V. Charged cyclodextrin derivatives and their use in plant cell and tissue culture growth media
US7678068B2 (en) 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
WO2004049982A2 (en) 2002-12-02 2004-06-17 Gi Dynamics, Inc. Bariatric sleeve
US7766973B2 (en) 2005-01-19 2010-08-03 Gi Dynamics, Inc. Eversion resistant sleeves
US7608114B2 (en) 2002-12-02 2009-10-27 Gi Dynamics, Inc. Bariatric sleeve
US7491234B2 (en) 2002-12-03 2009-02-17 Boston Scientific Scimed, Inc. Medical devices for delivery of therapeutic agents
US7758881B2 (en) 2004-06-30 2010-07-20 Advanced Cardiovascular Systems, Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US7666216B2 (en) 2002-12-24 2010-02-23 Novostent Corporation Delivery catheter for ribbon-type prosthesis and methods of use
US7311727B2 (en) 2003-02-05 2007-12-25 Board Of Trustees Of The University Of Arkansas Encased stent
US20050107870A1 (en) 2003-04-08 2005-05-19 Xingwu Wang Medical device with multiple coating layers
US20040267347A1 (en) 2003-05-01 2004-12-30 Cervantes Marvin John Protective elongated sleeve for stent systems
US7931695B2 (en) 2003-07-15 2011-04-26 Kensey Nash Corporation Compliant osteosynthesis fixation plate
US7744620B2 (en) 2003-07-18 2010-06-29 Intervalve, Inc. Valvuloplasty catheter
US7169405B2 (en) 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
US7296998B2 (en) 2003-09-22 2007-11-20 Bartee Chaddick M Hydrophilic high density PTFE medical barrier
US7208008B2 (en) 2003-10-02 2007-04-24 Medtronic Vascular, Inc. Balloonless direct stenting device
US7618647B2 (en) 2003-10-03 2009-11-17 Boston Scientific Scimed, Inc. Using bucky paper as a therapeutic aid in medical applications
NZ546981A (en) 2003-11-07 2009-10-30 Nobil Bio Ricerche Srl Method for preparing drug eluting medical devices and devices obtained therefrom
CA2536042A1 (en) 2003-11-10 2005-06-02 Angiotech International Ag Medical implants and anti-scarring agents
US8465453B2 (en) 2003-12-03 2013-06-18 Mayo Foundation For Medical Education And Research Kits, apparatus and methods for magnetically coating medical devices with living cells
US20090118817A1 (en) 2005-06-16 2009-05-07 Mayo Foundation For Medical Education And Research Magnetic Medical Apparatus, Kits, and Methods
US7723395B2 (en) 2004-04-29 2010-05-25 Kensey Nash Corporation Compressed porous materials suitable for implant
WO2005055800A2 (en) 2003-12-15 2005-06-23 Technion Research & Development Foundation Ltd. Therapeutic drug-eluting endoluminal covering
US20050159805A1 (en) 2004-01-20 2005-07-21 Jan Weber Functional coatings and designs for medical implants
US20050272153A1 (en) 2004-01-27 2005-12-08 Zou Xuenong Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal
TWI434676B (zh) 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
WO2005094526A2 (en) 2004-03-24 2005-10-13 Corium International, Inc. Transdermal delivery device
US8003122B2 (en) 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7465318B2 (en) 2004-04-15 2008-12-16 Soteira, Inc. Cement-directing orthopedic implants
US7578834B2 (en) 2004-05-03 2009-08-25 Abdou M S Devices and methods for the preservation of spinal prosthesis function
US7704545B2 (en) 2004-05-12 2010-04-27 Medtronic Vascular, Inc. Drug-polymer coated stent
US7758654B2 (en) 2004-05-20 2010-07-20 Kensey Nash Corporation Anti-adhesion device
US7785615B2 (en) 2004-05-28 2010-08-31 Cordis Corporation Biodegradable medical implant with encapsulated buffering agent
US20050278011A1 (en) 2004-06-10 2005-12-15 Peckham John E Stent delivery system
US20050288766A1 (en) 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US7402172B2 (en) 2004-10-13 2008-07-22 Boston Scientific Scimed, Inc. Intraluminal therapeutic patch
EP1812090A1 (en) 2004-10-28 2007-08-01 Microchips, Inc. Orthopedic and dental implant devices providing controlled drug delivery
US7771382B2 (en) 2005-01-19 2010-08-10 Gi Dynamics, Inc. Resistive anti-obesity devices
DE102005007596A1 (de) 2005-02-18 2006-08-24 Breeze Medical, Inc., Boca Raton Überzug, Herstellungsverfahren und Verfahren zum Aufbringen eines Überzuges auf ein medizinisches Instrument sowie medizinisches Instrument
EP1855625A2 (en) 2005-02-18 2007-11-21 Zimmer, Inc. Prosthetic hip stem with fully porous layer
TW200714289A (en) 2005-02-28 2007-04-16 Genentech Inc Treatment of bone disorders
US20090234453A1 (en) 2005-03-17 2009-09-17 Active Implants Corporation Implant devices
DE102005017023A1 (de) 2005-04-13 2006-10-19 Bayer Materialscience Ag UV-stabilisierte Polycarbonatformkörper
US20070038299A1 (en) * 2005-08-12 2007-02-15 Arthrotek, Inc Multilayer microperforated implant
US7789915B2 (en) 2005-08-31 2010-09-07 Vance Products Incorporated Stent for implantation
US7550012B2 (en) 2005-08-31 2009-06-23 Cook Ireland Limited Stent for implantation
NL1030364C2 (nl) 2005-11-07 2007-05-08 Ft Innovations Fti B V Implantaat en werkwijze voor het vervaardigen van een dergelijk implantaat.
US20070142892A1 (en) 2005-12-15 2007-06-21 Vipul Bhupendra Dave Self-expanding stent delivery system
US8048443B2 (en) 2005-12-16 2011-11-01 Cerapedics, Inc. Pliable medical device and method of use
ATE520425T1 (de) 2006-02-07 2011-09-15 Tepha Inc Verstärkte polymilchsäurepolymere und -copolymere
US8591531B2 (en) 2006-02-08 2013-11-26 Tyrx, Inc. Mesh pouches for implantable medical devices
AU2007344645B2 (en) 2006-02-08 2012-12-13 Medtronic, Inc. Temporarily stiffened mesh prostheses
US8197536B2 (en) 2006-03-10 2012-06-12 Cordis Corporation Method for placing a medical device at a bifurcated conduit
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8795711B2 (en) 2006-03-31 2014-08-05 Mati Therapeutics Inc. Drug delivery methods, structures, and compositions for nasolacrimal system
CN101495065B (zh) 2006-04-25 2014-07-23 泰里福来克斯医学公司 磷酸钙聚合物复合材料及其制备方法
CN101432131B (zh) * 2006-04-27 2013-03-27 3M创新有限公司 具有吸音特性的结构化薄膜
US20080026263A1 (en) * 2006-06-28 2008-01-31 Leboe David A Startup circuit for electronics in a hazardous environment
US9468746B2 (en) 2006-08-22 2016-10-18 Medtronic Vascular, Inc. Systems and methods for local bioactive material delivery
US20080057096A1 (en) 2006-08-29 2008-03-06 Den-Mat Corporation Biocompatible stent
US20100028402A1 (en) 2006-10-25 2010-02-04 Marina Dobrovolskaia Nanoparticle-based anticoagulant
US9023114B2 (en) * 2006-11-06 2015-05-05 Tyrx, Inc. Resorbable pouches for implantable medical devices
US20080107711A1 (en) 2006-11-08 2008-05-08 Alexis Paul Shelokov Bioabsorbable Implantable Material Fortified with Antibiotics for Localized Delivery of Drugs
CN102973343B (zh) 2006-11-22 2015-12-09 印斯拜尔Md有限公司 优化的支架套
GB0702864D0 (en) 2007-02-14 2007-03-28 Benoist Girard Sas Prosthetic implant for use without bone cement
JP2008224297A (ja) 2007-03-09 2008-09-25 Hitachi High-Technologies Corp 自動分析装置および自動分析装置用の小容量試薬容器
US8911765B2 (en) 2007-03-29 2014-12-16 Tyrx, Inc. Biodegradable, polymer coverings for breast implants
US8430852B2 (en) 2007-04-17 2013-04-30 Medtronic, Inc. Therapeutic sleeve for implantable medical device
US9216101B2 (en) 2007-07-10 2015-12-22 Boston Scientific Scime, Inc. Dual taper stent protector
US9492278B2 (en) 2007-07-10 2016-11-15 Warsaw Orthopedic, Inc. Delivery system
US20090081276A1 (en) 2007-08-13 2009-03-26 Eben Alsberg Bioresorbable implant composition
US20090069904A1 (en) * 2007-09-12 2009-03-12 Applied Medical Research Biomaterial including micropores
AR066166A1 (es) 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
EP2052700A1 (en) 2007-09-26 2009-04-29 Microchips, Inc. Drug delivery device and method for use with prosthetic device implantation
RU77539U1 (ru) * 2007-09-26 2008-10-27 Николай Алексеевич Алешин Пластина для челюстно-лицевой хирургии
US8192479B2 (en) 2007-11-30 2012-06-05 Cook Medical Technologies Llc Method and device for vascular therapy
EP2080603A1 (en) 2008-01-18 2009-07-22 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Manufacturing film or sheet material having openings
JP2011513005A (ja) 2008-03-06 2011-04-28 ボストン サイエンティフィック サイムド，インコーポレイテッド シース被覆を備えたバルーンカテーテル装置
CN101587099B (zh) * 2008-05-21 2012-03-28 鸿富锦精密工业（深圳）有限公司 表面声波感测器的制作方法
CA2736649A1 (en) 2008-09-10 2010-03-18 Ev3 Inc. Stents and catheters having improved stent deployment
CN101402736A (zh) 2008-11-12 2009-04-08 华中科技大学 可生物降解的不饱和聚磷酸酯及其制备与应用方法
FR2941616B1 (fr) * 2009-01-30 2012-06-08 T H T Textile Hi Tec Plaque implantable pour la refection de parois
US20120010636A1 (en) * 2009-02-11 2012-01-12 Nanyang Technological University Multi-layered surgical prosthesis
US9339630B2 (en) 2009-02-19 2016-05-17 Medtronic Vascular, Inc. Retractable drug delivery system and method
US20100228333A1 (en) 2009-03-04 2010-09-09 William Joseph Drasler Drug eluting surface covering
US20100247600A1 (en) * 2009-03-24 2010-09-30 Warsaw Orthopedic, Inc. Therapeutic drug eluting implant cover and method of making the same
US20100249783A1 (en) 2009-03-24 2010-09-30 Warsaw Orthopedic, Inc. Drug-eluting implant cover
US8888847B2 (en) 2009-05-22 2014-11-18 Medtronic, Inc. Cover having self-anchoring protrusions for use with an implantable medical device
JP2011216178A (ja) 2010-03-18 2011-10-27 Panasonic Corp 再生装置、再生システム及びサーバ
JP2011207847A (ja) * 2010-03-30 2011-10-20 Nitto Denko Corp フィルム状製剤及びその製造方法
CN102958555A (zh) 2010-04-28 2013-03-06 金伯利-克拉克环球有限公司 注射成型微针阵列和用于形成该微针阵列的方法
US8697117B2 (en) * 2010-08-02 2014-04-15 Ramot At Tel-Aviv University Ltd. Drug-eluting films
CA2807376A1 (en) * 2010-08-02 2012-02-09 Euclid Systems Corporation Collagen-based implants for sustained delivery of drugs
CN101912663B (zh) 2010-08-18 2013-09-04 清华大学 空心微针阵列芯片、经皮给药贴片、器件及制备方法
JP2013005984A (ja) 2011-06-27 2013-01-10 Kyocera Medical Corp 骨プレート
WO2013013172A1 (en) 2011-07-20 2013-01-24 The University Of Utah Research Foundation Intravaginal devices for drug delivery
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3719736A (en) * 1970-10-08 1973-03-06 Gen Foods Corp Method of producing perforated plastic film
US5326356A (en) * 1990-06-01 1994-07-05 Fidia S.P.A. Biocompatible perforated membranes, processes for their preparation, their use as a support in the in vitro growth of epithelial cells, the artificial skin obtained in this manner, and its use in skin grafts
CN1130175C (zh) * 1994-06-30 2003-12-10 普罗克特和甘保尔公司 具有表面能量梯度的絮网、絮网制造方法和吸湿用品
CN101437571A (zh) * 2005-10-13 2009-05-20 斯恩蒂斯有限公司 载药包装物
US20090192609A1 (en) * 2008-01-29 2009-07-30 Zimmer, Inc. Implant device for use in an implant system
US20110268781A1 (en) * 2009-11-09 2011-11-03 Gore Enterprise Holdings, Inc. Drug eluting composite

Also Published As

Publication number Publication date
US20160287527A1 (en) 2016-10-06
AU2012362432B2 (en) 2017-06-22
EP3466359A1 (en) 2019-04-10
EP2797530A1 (en) 2014-11-05
CN104135954B (zh) 2017-11-07
KR20140107612A (ko) 2014-09-04
JP6342330B2 (ja) 2018-06-13
TW201343207A (zh) 2013-11-01
CA2862343C (en) 2020-04-14
BR112014016086A8 (pt) 2017-07-04
KR102127615B1 (ko) 2020-07-01
AU2012362432A1 (en) 2014-07-31
WO2013101867A1 (en) 2013-07-04
EP2797530B1 (en) 2018-09-26
US20130171410A1 (en) 2013-07-04
TWI590843B (zh) 2017-07-11
US10617653B2 (en) 2020-04-14
RU2014130749A (ru) 2016-02-20
US9381683B2 (en) 2016-07-05
US20200222335A1 (en) 2020-07-16
CA2862343A1 (en) 2013-07-04
BR112014016086A2 (pt) 2017-06-13
JP2015503403A (ja) 2015-02-02
EP3466359B1 (en) 2023-06-07
RU2630544C2 (ru) 2017-09-11

Similar Documents

Publication Publication Date Title
CN104135954A (zh) 膜及制造方法
KR101377900B1 (ko) 약물-함침 용기
US10500304B2 (en) Films and methods of manufacture
JP6914929B2 (ja) 外科用インプラントとその製造プロセス
EP3043833B1 (en) Tubular porous foam scaffolds with gradient pores for tissue engineering
US8236350B2 (en) Polymer for tissue engineering applications and drug delivery
JP2012148075A (ja) 細孔内フィルムを備える医療デバイス
TWI241199B (en) Method for manufacturing porous bioresorbable material having interconnected pores

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant